LYNX DX, INC.

Northville, MI · Founded 2015 · CIK 0001799277 · Medtech · Private

Urine biomarker assay combining TMPRSS2:ERG fusion and PCA3 gene detection with PSA to generate MPS risk score for prostate cancer diagnosis

lynxdx.com →
Grants
$3.0M
2 awards
Sector median: 1
Raised
$925K
1 Form D · Jan 2020
80 months since last filing
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$925,000
Federal grantDepartment of Health and Human Services · Phase II · Urine Diagnostic Tool for the Detection of High-grade Prostate Cancer$1,999,642
Federal grantDepartment of Health and Human Services · Phase II · Urine Diagnostic Tool for the Detection of High-grade Prostate Cancer$995,327
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1340OncoVerity, Inc.—$18M
1341Persperion Diagnostics Inc.—$4.4M
1342Eyedaptic, Inc.—$928K
1343LYNX DX, INC.—$925K
1344Aethon Medical——
1345Simulated Inanimate Models LLC—$900K
1346NOVOPYXIS INC.—$856K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Arul ChinnaiyanDirector · Executive Officer
  • Matt MartinExecutive Officer
  • Yashar NikafsExecutive Officer

Patents

USPTO · 0 granted of 3
  • Methods For Rna Extraction And Detection From A Urine Sampleapplication
  • Methods For Rna Extraction And Detection From A Urine Sampleapplication
  • Methods For Rna Extraction And Detection From A Urine Sampleapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.